TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT04336072 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02960607 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02960607 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00960492 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT00960492 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT00960492 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT02692755 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02692755 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02883894 — Safety Biomarker (SAF): Anti-BP180 autoantibody
Study NCT03449069 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT02497599 — Predictive Biomarker (PRD): Carbonic anhydrase IX
Genes: CA9; G250; MN
Study NCT03795324 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study NCT03795324 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01440231 — Predictive Biomarker (PRD): TNFSF13 mRNA
Genes: TNFSF13; APRIL; TALL2; ZTNF2; UNQ383/PRO715
Study NCT02211248 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04324983 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT02097472 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03091920 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01764555 — Predictive Biomarker (PRD): CYP2E1 mRNA
Genes: CYP2E1; CYP2E
Study NCT03342807 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT01874886 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT01756625 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03718767 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT03718767 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT02827773 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03173235 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT02218346 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT04148976 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04148976 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT02916901 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01919866 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02728453 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT03474731 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03474731 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03406351 — Safety Biomarker (SAF): miR-142
Genes: MIR142
Study NCT03894618 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT01194960 — Predictive Biomarker (PRD): TPBG mRNA
Genes: TPBG; 5T4
Study NCT03056755 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT03056755 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03056755 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03214354 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study NCT03214354 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT02067936 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00226382 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02637687 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study NCT02637687 — Predictive Biomarker (PRD): NTRK2 mRNA
Genes: NTRK2; TRKB
Study NCT02637687 — Predictive Biomarker (PRD): NTRK3 mRNA
Genes: NTRK3; TRKC
Study NCT00001231 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01295671 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00000825 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00000825 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03903419 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT00512876 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04327570 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04406324 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03822767 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02697578 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT00625079 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT04086745 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05504057 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02732964 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03264989 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT00902122 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT03060109 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT03720158 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03720158 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT03900182 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03900182 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT03900182 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT02942355 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02942355 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02942355 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT02942355 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01377688 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02936206 — Predictive Biomarker (PRD): CCND1
Genes: U21B31
Study NCT02936206 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03805919 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT06726967 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT03301350 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03301350 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02168218 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study NCT02168218 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04263051 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02912403 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00302211 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT02452424 — Predictive Biomarker (PRD): CSF1R mRNA
Genes: CSF1R; FMS
Study NCT02452424 — Predictive Biomarker (PRD): CSF1 mRNA
Genes: CSF1
Study NCT04158583 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT01792037 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04221945 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04097561 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04097561 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03083600 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00806663 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01131910 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00385931 — Safety Biomarker (SAF): Coagulation factor IIa
Genes: F2
Study NCT00385931 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study NCT00385931 — Monitoring Biomarker (MOI): Matrix metalloproteinase 1
Genes: MMP1; CLG
Study NCT00385931 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study NCT01025063 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00701272 — Predictive Biomarker (PRD): FGL2 mRNA
Genes: FGL2
Study NCT00227409 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00924768 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT03633110 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00384228 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT02551263 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02038335 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02038335 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT02510001 — Predictive Biomarker (PRD): MAP2K1 mRNA
Genes: MAP2K1; MEK1; PRKMK1
Study NCT02510001 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT04321044 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00031759 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT03366181 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03366181 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03366181 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT00969033 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT01409876 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT04493853 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT03705091 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study NCT02469194 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03753165 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00949351 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00249847 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC6A4 mRNA
Genes: SLC6A4; HTT; SERT
Study NCT03629522 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00785980 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT04331717 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT02306538 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03737955 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT03736434 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04025073 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT04025073 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04025073 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT04025073 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00924196 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT03329092 — Predictive Biomarker (PRD): MBL2 mRNA
Genes: MBL2; COLEC1; MBL
Study NCT00000528 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04718038 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04718038 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT04331470 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03494296 — Predictive Biomarker (PRD): DNMT1 mRNA
Genes: DNMT1; AIM; CXXC9; DNMT
Study NCT01108770 — Predictive Biomarker (PRD): EDA mRNA
Genes: EDA; ED1; EDA2
Study NCT00889876 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04090333 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT02134717 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT03930602 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT04340167 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT04340167 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03856879 — Predictive Biomarker (PRD): ID1 mRNA
Genes: ID1; BHLHB24; ID
Study NCT00004893 — Safety Biomarker (SAF): Interleukin 12
Study NCT04215159 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01634620 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT02005458 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03049475 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT03033862 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03033862 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT00001467 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00233272 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03218436 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT04851054 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04851054 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01272037 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01272037 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01818596 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04402879 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02742220 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02421796 — Safety Biomarker (SAF): Human leucocyte antigen
Study NCT03531086 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study NCT02097108 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04346667 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05591976 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02914405 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02442349 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03744767 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01097057 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT00031148 — Predictive Biomarker (PRD): FGF7 mRNA
Genes: FGF7; KGF
Study NCT00239928 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT01440088 — Predictive Biomarker (PRD): TH mRNA
Genes: TH; TYH
Study NCT03862183 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01787630 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02256956 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT04383457 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03994666 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT03386721 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT03386721 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03386721 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT01907464 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00018889 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT00088335 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT00497289 — Predictive Biomarker (PRD): LCT mRNA
Genes: LCT; LPH
Study NCT02416739 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02416739 — Predictive Biomarker (PRD): RUNX3 mRNA
Genes: RUNX3; AML2; CBFA3; PEBP2A3
Study NCT03986931 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02309801 — Predictive Biomarker (PRD): ALDH2 mRNA
Genes: ALDH2; ALDM
Study NCT02853097 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT02853097 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT02784665 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT02784665 — Predictive Biomarker (PRD): MPL mRNA
Genes: MPL; TPOR
Study NCT02488005 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02488005 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04702841 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT02326597 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05937061 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02789566 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT00899756 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00899756 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03863665 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01424982 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT01424982 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT03439735 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT03439735 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03439735 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03439735 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01730092 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01730092 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06385483 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00357643 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01433926 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00266045 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT01349569 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03741127 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT01621581 — Predictive Biomarker (PRD): GDNF mRNA
Genes: GDNF
Study NCT00259948 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00032734 — Surrogate Endpoint (SUR): Serum sodium
Study NCT02843841 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT02843841 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02843841 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study NCT04226430 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04226430 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04079868 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04382066 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03906539 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00628732 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT03339050 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00114855 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04066114 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT04628429 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04544657 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study NCT04544657 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02414893 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT01326364 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01326364 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00179439 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT01867502 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00931606 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01816594 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01816594 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT01816594 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT04363801 — Predictive Biomarker (PRD): DKK1 mRNA
Genes: DKK1; UNQ492/PRO1008
Study NCT04512430 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03842228 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT00089063 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03774628 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02676479 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study NCT04311489 — Pharmacodynamic Biomarker (PDY): Cyclic guanosine monophosphate
Study NCT03953300 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00704938 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT00704938 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT00089726 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04068246 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study NCT00297154 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03651011 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03651011 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01496469 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02984228 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03477396 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02084550 — Predictive Biomarker (PRD): PI3 mRNA
Genes: PI3; WAP3; WFDC14
Study NCT03910868 — Predictive Biomarker (PRD): ABCC2 mRNA
Genes: ABCC2; CMOAT; CMOAT1; CMRP; MRP2
Study NCT03910868 — Predictive Biomarker (PRD): CNT3 mRNA
Genes: SLC28A3; CNT3
Study NCT01842139 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT00861627 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00861627 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04309175 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00001543 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study NCT03910205 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03910205 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4